Last summer, Project CBD helped recruit subjects for a large-scale clinical study to assess the safety and efficacy of the daily use of cannabidiol. Good news: Contrary to FDA warnings, preliminary results of the ValidCare study show “no clinical evidence of liver disease in any of the participants.”